Comparison of Two Different Doses of Azithromycin for Treatment of Yaws
Randomized Controlled Trial Comparing Efficacy of Single Dose Treatment of Yaws With 20mg/kg Versus 30mg/kg of Azithromycin
Sponsor: Barcelona Institute for Global Health
Listed as NCT02344628, this PHASE3 trial focuses on Yaws and remains completed. Sponsored by Barcelona Institute for Global Health, it has been updated 11 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Feb 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Feb 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE3
-
Nov 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Nov 2018 [monthly]
Completed PHASE3
-
Mar 2017 — Jun 2018 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Feb 2017 — Mar 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Jun 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Barcelona Institute for Global Health
- Centers for Disease Control and Prevention
- Ghana Health Services
- Kwame Nkrumah University of Science and Technology
- London School of Hygiene and Tropical Medicine
- Noguchi Memorial Institute for Medical Research
- Papua New Guinea Institute of Medical Research
- Papua New Guinea National Department of Health
- University of Health and Allied Sciences
- World Health Organization
For direct contact, visit the study record on ClinicalTrials.gov .